Differences in Uptravi maintenance doses had no impact on the risk of hospitalization among adults with PAH, a claims ...

At close: September 25 at 4:00 PM EDT Loading Chart for UTHR ...

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...

Investigators say more research is warranted to optimize management of patients with pulmonary arterial hypertension (PAH) ...

The key targets in the Raynauds Disease pipeline products market include Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1), Prostaglandin E Synthase (Microsomal Glutathione S ...

The clinical significance and frequency of adverse events with tNSAIDs in the lower GI tract have been increasingly reported, but are much more poorly characterized than those from the upper GI ...

Table 1. Suggested strategies for analgesic/anti-inflammatory treatment and cardiovascular prevention among patients with inflammatory disease and different levels of risk of vascular events ...

United Therapeutics is also in search of an effective medicine with trepostinil, a prostacyclin mimetic, currently in phase 3 development for IPF. As is Bristol-Myers Squibb, recently announcing ...

They also produce signaling molecules like nitric oxide and prostacyclin to maintain vascular balance. However, EC ...

In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...